BRIEF-DBV Technologies receives FDA breakthrough therapy designation for Viaskin peanut By: Reuters: Company News April 09, 2015 at 01:12 AM EDT * Receives FDA breakthrough therapy designation for Viaskin peanut for the treatment of peanut allergy in children Read More >>